MARATTO

review · Future Medicinal Chemistry

3,5-Disubstituted pyrazoline as a promising core for anticancer agents: mechanisms of action and therapeutic potentials

20252 citationsOpen accessSinai University

Abstract

antiproliferative effects and biochemical investigations of probable mechanisms of action. Nevertheless, many reported pyrazoline-bearing compounds have anticancer activity without an explored mode of action, which opens new research avenues to examine their biochemical profiles further. Therefore, 3,5-disubstituted pyrazoline is a promising core that can be used to design new derivatives with anticancer activity based on the structure-activity relationship summarized in this review to obtain higher potency and selectivity.

Research topics

  • Synthesis and biological activity
  • Bioactive Compounds and Antitumor Agents
  • Cancer therapeutics and mechanisms

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/17568919.2025.2476393

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.